Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.67SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.2.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.88SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.1.48SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.16.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.134SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BY.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BM.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BM.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.42SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XAY.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.258.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
B.1.160.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.71SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.445SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.21 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AT.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.199SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.1.112SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
B.1.1.123SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.143SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.48SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.46.6.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
AY.112.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.1.360SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.49SYoung-STATACATGTCTCTGGGACCA20452176321782F-825.395Singapore
B.1.160.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.385SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.384SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.338SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BG.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.20.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
XVSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.38.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.80SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.619.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.12.1 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used